Learning to Listen Fall 2024: Episode 1

Samuel Pang, MD is a board-certified OB/GYN and Reproductive Endocrinologist, and, beginning in 1998, one of the first physicians to provide reproductive care to members of the LGBTQ+ community. His pioneering work has led to numerous advances along the way and earned him the prestigious Arnold P. Gold Humanism in Medicine Award in 2022.  is a pioneer in providing reproductive care to LGBTQ+ patients. In 1998, he was among the earliest physicians to apply ART to gay men who sought parenthood via donor eggs and gestational surrogacy. In 2007, he began providing IVF services to lesbian couples without infertility, coining the term “reciprocal IVF” for one person providing oocytes and the other gestating. In 2012, he began treating transgender men for fertility preservation, reciprocal IVF, and transgender men who choose to gestate themselves. He was a charter member and second chairperson of ASRM’s LGBTQSIG. In 2022, Dr. Pang received the “Arnold P. Gold Foundation Humanism in Medicine Award” for practicing physicians from ASRM.

After earning his BSc (Biochemistry) and MD from the University of British Columbia, Samuel C. Pang, MD completed a rotating internship followed by a residency in Obstetrics & Gynecology at the University of Toronto. He completed his fellowship in Reproductive Endocrinology at UCLA. He is board-certified in Obstetrics & Gynecology and Reproductive Endocrinology & Infertility. In 1993, he joined IVF America Boston (later, Reproductive Science Center of New England) and was appointed Medical Director of RSCNE in 2007. In October 2014, he joined Boston IVF following a merger with RSCNE. Dr. Pang has a reputation for commitment to excellence and meticulous attention to detail in patient care, and he is respectful, empathic, sensitive, and compassionate in communicating with patients, engendering their trust and confidence. While his career focused on patient care, he has also mentored junior physician colleagues and advocated for patients. Working with RESOLVE New England, he played an instrumental role in the 2011 revision to the Massachusetts Infertility Insurance Mandate.